Cargando…

Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30

PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigu...

Descripción completa

Detalles Bibliográficos
Autores principales: Regnault, Antoine, Pompilus, Farrah, Ciesluk, Anna, Mazerolle, Flora, Bejar, Rafael, Fram, Robert J., Faller, Douglas V., Marquis, Patrick, Bell, Jill A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292469/
https://www.ncbi.nlm.nih.gov/pubmed/34283303
http://dx.doi.org/10.1186/s41687-021-00334-w
_version_ 1783724836919443456
author Regnault, Antoine
Pompilus, Farrah
Ciesluk, Anna
Mazerolle, Flora
Bejar, Rafael
Fram, Robert J.
Faller, Douglas V.
Marquis, Patrick
Bell, Jill A.
author_facet Regnault, Antoine
Pompilus, Farrah
Ciesluk, Anna
Mazerolle, Flora
Bejar, Rafael
Fram, Robert J.
Faller, Douglas V.
Marquis, Patrick
Bell, Jill A.
author_sort Regnault, Antoine
collection PubMed
description PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigue measures based on the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 items (QLQ-C30) and a customized selection of 10 supplemental items from the EORTC Item Library. METHODS: The 40 items were completed online cross-sectionally by 51 patients (higher risk [HR] MDS: 53%; CMML: 26%; AML: 10%). Psychometric analyses based on Rasch measurement theory (RMT) were conducted on the QLQ-C30 physical functioning and fatigue domains as well as measures combining QLQ-C30 and supplemental items. A measure of anemia-related symptoms composed of QLQ-C30 and supplemental items covering fatigue, dyspnea, and dizziness was also investigated. RESULTS: The QLQ-C30 physical functioning and fatigue domains showed good targeting to the sample and adequate reliability, with few conceptual gaps identified. Combining the QLQ-C30 and supplemental physical functioning and fatigue items improved the conceptual coverage and the reliability of the measures. The patient-reported anemia-related symptom measure showed good measurement performance, underpinned by a clinically meaningful characterization of severity of these symptoms over a spectrum, starting with fatigue, then dyspnea, and finally dizziness (most severe). CONCLUSION: The modular measurement approach of combining EORTC QLQ-C30 and Item Library offers a promising pragmatic solution to the measurement of physical functioning and fatigue, as well as anemia-related symptoms in clinical trials conducted in HR MDS, CMML, and AML. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00334-w.
format Online
Article
Text
id pubmed-8292469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82924692021-08-05 Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30 Regnault, Antoine Pompilus, Farrah Ciesluk, Anna Mazerolle, Flora Bejar, Rafael Fram, Robert J. Faller, Douglas V. Marquis, Patrick Bell, Jill A. J Patient Rep Outcomes Research PURPOSE: Physical functioning and fatigue are key patient concerns in myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). The objective of this research was to generate supportive quantitative evidence for modular physical functioning and fatigue measures based on the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 items (QLQ-C30) and a customized selection of 10 supplemental items from the EORTC Item Library. METHODS: The 40 items were completed online cross-sectionally by 51 patients (higher risk [HR] MDS: 53%; CMML: 26%; AML: 10%). Psychometric analyses based on Rasch measurement theory (RMT) were conducted on the QLQ-C30 physical functioning and fatigue domains as well as measures combining QLQ-C30 and supplemental items. A measure of anemia-related symptoms composed of QLQ-C30 and supplemental items covering fatigue, dyspnea, and dizziness was also investigated. RESULTS: The QLQ-C30 physical functioning and fatigue domains showed good targeting to the sample and adequate reliability, with few conceptual gaps identified. Combining the QLQ-C30 and supplemental physical functioning and fatigue items improved the conceptual coverage and the reliability of the measures. The patient-reported anemia-related symptom measure showed good measurement performance, underpinned by a clinically meaningful characterization of severity of these symptoms over a spectrum, starting with fatigue, then dyspnea, and finally dizziness (most severe). CONCLUSION: The modular measurement approach of combining EORTC QLQ-C30 and Item Library offers a promising pragmatic solution to the measurement of physical functioning and fatigue, as well as anemia-related symptoms in clinical trials conducted in HR MDS, CMML, and AML. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41687-021-00334-w. Springer International Publishing 2021-07-20 /pmc/articles/PMC8292469/ /pubmed/34283303 http://dx.doi.org/10.1186/s41687-021-00334-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Regnault, Antoine
Pompilus, Farrah
Ciesluk, Anna
Mazerolle, Flora
Bejar, Rafael
Fram, Robert J.
Faller, Douglas V.
Marquis, Patrick
Bell, Jill A.
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title_full Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title_fullStr Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title_full_unstemmed Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title_short Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30
title_sort measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on eortc qlq-c30
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292469/
https://www.ncbi.nlm.nih.gov/pubmed/34283303
http://dx.doi.org/10.1186/s41687-021-00334-w
work_keys_str_mv AT regnaultantoine measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT pompilusfarrah measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT cieslukanna measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT mazerolleflora measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT bejarrafael measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT framrobertj measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT fallerdouglasv measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT marquispatrick measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30
AT belljilla measuringpatientreportedphysicalfunctioningandfatigueinmyelodysplasticsyndromesusingamodularapproachbasedoneortcqlqc30